Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

BUY
$168.19 - $186.01 $113,191 - $125,184
673 New
673 $120,000
Q1 2022

May 10, 2022

SELL
$158.14 - $179.59 $106,111 - $120,504
-671 Closed
0 $0
Q4 2021

Jun 28, 2022

SELL
$155.93 - $173.01 $21,050 - $23,356
-135 Reduced 16.75%
671 $115,000
Q3 2021

Nov 15, 2021

SELL
$161.5 - $179.47 $133,237 - $148,062
-825 Reduced 50.58%
806 $130,000
Q2 2021

Jun 28, 2022

SELL
$159.48 - $171.07 $1.31 Million - $1.4 Million
-8,211 Reduced 83.43%
1,631 $269,000
Q2 2021

Aug 09, 2021

BUY
$159.48 - $171.07 $1.3 Million - $1.4 Million
8,176 Added 490.76%
9,842 $1.63 Million
Q1 2021

Jun 28, 2022

SELL
$153.07 - $170.48 $1.26 Million - $1.4 Million
-8,211 Reduced 83.13%
1,666 $274,000
Q1 2021

May 13, 2021

BUY
$153.07 - $170.48 $1.11 Million - $1.23 Million
7,219 Added 271.6%
9,877 $324,000
Q4 2020

Feb 11, 2021

BUY
$137.11 - $157.38 $87,476 - $100,408
638 Added 31.58%
2,658 $418,000
Q3 2020

Nov 02, 2020

BUY
$140.38 - $153.83 $31,866 - $34,919
227 Added 12.66%
2,020 $301,000
Q2 2020

Jul 29, 2020

SELL
$128.81 - $155.51 $277,971 - $335,590
-2,158 Reduced 54.62%
1,793 $252,000
Q1 2020

May 06, 2020

BUY
$111.14 - $153.99 $351,091 - $486,454
3,159 Added 398.86%
3,951 $518,000
Q4 2019

Feb 10, 2020

SELL
$127.5 - $146.44 $189,082 - $217,170
-1,483 Reduced 65.19%
792 $116,000
Q3 2019

Oct 31, 2019

BUY
$126.95 - $142.14 $288,811 - $323,368
2,275 New
2,275 $295,000
Q2 2019

Jul 29, 2019

SELL
$131.15 - $144.24 $361,055 - $397,092
-2,753 Closed
0 $0
Q4 2018

Feb 07, 2019

SELL
$122.84 - $147.84 $71,247 - $85,747
-580 Reduced 17.4%
2,753 $355,000
Q3 2018

Nov 08, 2018

SELL
$121.58 - $142.88 $21,641 - $25,432
-178 Reduced 5.07%
3,333 $461,000
Q1 2018

May 11, 2018

BUY
$125.1 - $148.14 $342,648 - $405,755
2,739 Added 354.79%
3,511 $450,000
Q4 2017

Feb 12, 2018

BUY
$131.22 - $143.62 $101,301 - $110,874
772
772 $108,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Stelac Advisory Services LLC Portfolio

Follow Stelac Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stelac Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stelac Advisory Services LLC with notifications on news.